Dagode, Salvacion L.

HRN: 12-71-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2023
CEFTAZIDIME 1GM (VIAL)
11/09/2023
11/15/2023
IVTT
1g
Q8
AGE With Mod DHN; UTI
Waiting Final Action 
11/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/09/2023
11/15/2023
IVTT
500 Mg
Q8
AGE With Mod DHN; T/c Intestinal Amoebiasis
Waiting Final Action 
11/09/2023
MUPIROCIN 2%, 15G (TUBE)
11/09/2023
11/15/2023
IVTT
Apply On Affected Areas
Bid
T/c Staphylococcal Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: